Paul Smith

Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis

Myeloid-derived suppressor cells coming of age

Perceived discrimination and health: A meta-analytic review.

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

CD22 blockade restores homeostatic microglial phagocytosis in ageing brains

Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions

The molecular basis for functional plasticity in type I interferon signaling

Myeloid-derived suppressor cells as regulators of the immune system

When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders

Sex differences in HPA axis responses to stress: a review

Cytokines sing the blues: inflammation and the pathogenesis of depression

The JAK/STAT signaling pathway: from bench to clinic

Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation

Interferons and viruses: an evolutionary arms race of molecular interactions

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

Major Depressive Disorder

Cancer-related fatigue—mechanisms, risk factors, and treatments

From inflammation to sickness and depression: when the immune system subjugates the brain

If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.

The molecular neurobiology of depression

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Mechanisms of Insulin Action and Insulin Resistance

Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide

Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion

Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy

Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945

Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response

Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis

Exposure to a Dysfunctional Glucocorticoid Receptor from Early Embryonic Life Programs the Resistance to Experimental Autoimmune Encephalomyelitis Via Nitric Oxide-Induced Immunosuppression